Mounjaro and Zepbound contain tirzepatide, developed by Eli Lilly
Pregnancy and breastfeeding Tirzepatide is not approved for use during pregnancy or breastfeeding
They may recommend transitioning to branded Mounjaro or Zepbound, or exploring other weight management medications that remain available through compounding pharmacies
Many doctors who guide patients through switching from Tirzepatide to Retatrutide emphasize patience during this early phase
Below, we break down how this stack works, who its for, and what results people are seeing based on real clinical insights from our medical team
It decreases overall appetite, food cravings, tendency to overeat, perceived hunger, and reactivity to foods